Document is current
Any future updates will be listed below
-
Authors
Abdul-Mutakabbir, Jacinda C. https://orcid.org/0000-0003-4162-6408
Abdul-Mutakabbir, Raheem
Casey, Samuel J.
-
Funding
Funding for this research was provided by:
Seqirus (96966741)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (K12HD113189)
- License Information
-
More Information
Article History
Received: 19 December 2025
Accepted: 26 January 2026
First Online: 5 March 2026
Declarations
:
: Jacinda C. Abdul-Mutakabbir is an Advisory Board member of Infectious Diseases and Therapy. Jacinda C. Abdul-Mutakabbir was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Jacinda C. Abdul-Mutakabbir received an honorarium from Shionogi, GSK, and Pfizer. All other authors (Raheem Abdul-Mutakabbir and Samuel J. Casey) have no conflicts to report.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration. The University of California, San Diego Institutional Review Board approved this study (#807857) and the waiver of informed consent, given the minimal risk and an anonymous collection of the data. Since the data were collected anonymously, the study was exempt from full board review.
